SCHEMBL16615855

SCHEMBL16615855

CC=C(N)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCCNC(=O)CC[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C(C)O)CN[C@@H](CO)C(=O)N1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MC1R Q01726 1/20 0.43
SRC P12931 3/20 0.42
SSTR2 P30874 1/20 0.41
SSTR4 P31391 1/20 0.41
SSTR5 P35346 1/20 0.41
MMP1 P03956 3/20 0.39
MMP2 P08253 3/20 0.39
MMP3 P08254 3/20 0.39
MMP9 P14780 3/20 0.39
MMP8 P22894 3/20 0.39
KDM1A O60341 1/20 0.39
RCOR1 Q9UKL0 1/20 0.39
OPRM1 P35372 2/20 0.39
OPRD1 P41143 2/20 0.39
OPRK1 P41145 2/20 0.39
REN P00797 2/20 0.38
TERF2 Q15554 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16615594 0.95 MC1R (0.46) MC1RSRCSSTR2SSTR4SSTR5
SCHEMBL16615755 0.81 STAT3 (0.43) MC1RSRCSSTR2SSTR4SSTR5
SCHEMBL16615868 0.81 MC1R (0.45) MC1RSRCSSTR2SSTR4SSTR5
SCHEMBL16615904 0.80 SRC (0.48) MC1RSRCSSTR2SSTR4SSTR5
SCHEMBL16615751 0.80 SSTR5 (0.47) MC1RSRCSSTR2SSTR4SSTR5
SCHEMBL16615864 0.79 SSTR5 (0.50) MC1RSRCSSTR2SSTR4SSTR5
SCHEMBL16691478 0.79 SRC (0.51) MC1RSRCSSTR2SSTR4SSTR5
SCHEMBL16615854 0.79 SSTR2 (0.50) MC1RSRCSSTR2SSTR4SSTR5
SCHEMBL16615896 0.78 MMP1 (0.41) SRCMMP1MMP2MMP3MMP9
SCHEMBL16615753 0.78 SRC (0.45) MC1RSRCSSTR2SSTR4SSTR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015044900-A1 THERAPEUTIC IMMUNOMODULATING COMPOUNDS AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2015-04-02 WO disclosed